{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:30:14Z","timestamp":1792845014481,"version":"4.5.0"},"reference-count":50,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R21HL170146"],"award-info":[{"award-number":["R21HL170146"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["R56AI175187"],"award-info":[{"award-number":["R56AI175187"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Secondary and tertiary lymphoid structures are a critical target of suppression in many autoimmune disorders, protein replacement therapies, and in transplantation. Although antigen-specific regulatory T cells (Tregs), such as chimeric antigen receptor (CAR) Tregs, generally persist longer and localize to target tissues more effectively than polyclonal Tregs in animal models, their numbers still progressively decline over time. A potential approach to maximize Treg activity in vivo is the expression of chemokine receptors such as CXCR5, which would enable localization of a greater number of engineered cells at sites of antigen presentation. Indeed, CXCR5 expression on follicular T helper cells and follicular Tregs enables migration toward lymph nodes, B cell zones, and tertiary lymphoid structures that appear in chronically inflamed non-lymphoid tissues.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this study, we generated human and murine CXCR5 co-expressing engineered receptor Tregs and tested them in preclinical mouse models of allo-immunity and hemophilia A, respectively. Additionally, we engineered a murine CXCR5 co-expressing clotting factor VIII (FVIII) specific T cell receptor fusion construct epsilon (FVIII TRuCe CXCR5) Treg to suppress anti-drug antibody development in a model of FVIII protein replacement therapy for hemophilia A.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In vitro, anti-HLA-A2 CXCR5+ CAR-Tregs showed enhanced migratory and antigen-specific suppressive capacities compared to untransduced Tregs. When injected into an NSG mouse model of HLA-A2+ pancreatic islet transplantation, anti-HLA-A2 CXCR5+ CAR-Tregs maintained a good safety profile allowing for long-term graft survival in contrast to anti-HLA-A2 CXCR5+ conventional CAR-T (Tconv) cells that eliminated the graft. Similarly, FVIII TRuCe CXCR5 Treg demonstrated increased in vivo persistence and suppressive capacity in a murine model of hemophilia A.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Collectively, our findings indicate that CXCR5 co-expression is safe and enhances in vivo localization and persistence in target tissues. This strategy can potentially promote targeted tolerance without the risk of off-target effects in multiple disease models.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1513009","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:51:32Z","timestamp":1751359892000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":7,"title":["CXCR5 engineered human and murine Tregs for targeted suppression in secondary and tertiary lymphoid organs"],"prefix":"10.3389","volume":"16","author":[{"given":"Matteo","family":"Doglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jyoti","family":"Rana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Stucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maite-Mu\u00f1oz","family":"Melero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Ugolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Jofra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiano","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Bercher-Brayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Carulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senthilkumar","family":"Thirumurugan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moanaro","family":"Biswas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Bonini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia","family":"Fousteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0041-4","article-title":"Next-generation regulatory T cell therapy","volume":"18","author":"Ferreira","year":"2019","journal-title":"Nat Rev Drug Discovery"},{"key":"B2","doi-asserted-by":"publisher","first-page":"104193","DOI":"10.1016\/j.cellimm.2020.104193","article-title":"Regulatory T cell therapy: Current and future design perspectives","volume":"356","author":"Rana","year":"2020","journal-title":"Cell Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2023.03.026","article-title":"Type 1 diabetes and inborn errors of immunity: Complete strangers or 2 sides of the same coin","volume":"151","author":"Mancuso","year":"2023","journal-title":"J Allergy Clin Immunol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-023-00985-4","article-title":"The immunology of type 1 diabetes","volume":"24","author":"Herold","year":"2024","journal-title":"Nat Rev Immunol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.01604","article-title":"Innovative approaches for immune tolerance to factor VIII in the treatment of hemophilia A","volume":"8","author":"Sherman","year":"2017","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000650","article-title":"Induction of activated T follicular helper cells is critical for anti-FVIII inhibitor development in hemophilia A mice","volume":"3","author":"Jing","year":"2019","journal-title":"Blood Adv"},{"key":"B8","doi-asserted-by":"publisher","first-page":"3971","DOI":"10.1182\/blood-2023-180998","article-title":"The tfh\/tfr pathway is pivotal in FVIII inhibitor development in mice","volume":"142","author":"Jing","year":"2023","journal-title":"Blood"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.16484","article-title":"Follicular T cells mediate donor-specific antibody and rejection after solid organ transplantation","volume":"21","author":"Mohammed","year":"2021","journal-title":"Am J Transplant"},{"key":"B10","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1186\/s13075-018-1690-0","article-title":"Enhanced IL-6\/phosphorylated STAT3 signaling is related to the imbalance of circulating T follicular helper\/T follicular regulatory cells in patients with rheumatoid arthritis","volume":"20","author":"Niu","year":"2018","journal-title":"Arthritis Res Ther"},{"key":"B11","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clim.2017.07.004","article-title":"The ratio of circulating follicular T helper cell to follicular T regulatory cell is correlated with disease activity in systemic lupus erythematosus","volume":"183","author":"Xu","year":"2017","journal-title":"Clin Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.2337\/db21-0091","article-title":"Reduced follicular regulatory T cells in spleen and pancreatic lymph nodes of patients with type 1 diabetes","volume":"70","author":"Vecchione","year":"2021","journal-title":"Diabetes"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864628","article-title":"Moving to the outskirts: interplay between regulatory T cells and peripheral tissues","volume":"13","author":"Estrada Brull","year":"2022","journal-title":"Front Immunol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-01-0177","article-title":"Regulatory T-cell compartmentalization and trafficking","volume":"108","author":"Wei","year":"2006","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1111\/imr.2019.289.issue-1","article-title":"Guidance factors orchestrating regulatory T cell positioning in tissues during development, homeostasis, and response","volume":"289","author":"Mempel","year":"2019","journal-title":"Immunol Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-016-2211-4","article-title":"Mechanisms of T cell organotropism","volume":"73","author":"Fu","year":"2016","journal-title":"Cell Mol Life Sci"},{"key":"B17","doi-asserted-by":"publisher","first-page":"102986","DOI":"10.1016\/j.jaut.2022.102986","article-title":"Engineered Treg cells: The heir to the throne of immunotherapy","volume":"144","author":"Stucchi","year":"2024","journal-title":"J Autoimmun"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1500801","article-title":"Control of regulatory T cell migration, function, and homeostasis","volume":"195","author":"Campbell","year":"2015","journal-title":"J Immunol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1182\/blood.2022018937","article-title":"Factor VIII trafficking to CD4+ T cells shapes its immunogenicity and requires several types of antigen-presenting cells","volume":"142","author":"Kaczmarek","year":"2023","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.00700117","article-title":"Donor-specific antibodies in kidney transplant recipients","volume":"13","author":"Zhang","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-023-00706-z","article-title":"The roles of tertiary lymphoid structures in chronic diseases","volume":"19","author":"Sato","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/cmi.2017.13","article-title":"Lymphotoxin signalling in tertiary lymphoid structures and immunotherapy","volume":"14","author":"Tang","year":"2017","journal-title":"Cell Mol Immunol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1231315","article-title":"Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer","volume":"14","author":"Esparcia-Pinedo","year":"2023","journal-title":"Front Immunol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-021-05453-z","article-title":"Identification and characterisation of tertiary lymphoid organs in human type 1 diabetes","volume":"64","author":"Korpos","year":"2021","journal-title":"Diabetologia"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.178.9.5643","article-title":"Tertiary lymphoid structures in the pancreas promote selection of B lymphocytes in autoimmune diabetes","volume":"178","author":"Kendall","year":"2007","journal-title":"J Immunol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.679909","article-title":"T follicular regulatory cells: choreographers of productive germinal center responses","volume":"12","author":"Lu","year":"2021","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2021.04.034","article-title":"CAR- and TRuC-redirected regulatory T cells differ in capacity to control adaptive immunity to FVIII","volume":"29","author":"Rana","year":"2021","journal-title":"Mol Ther"},{"key":"B28","doi-asserted-by":"publisher","first-page":"2542","DOI":"10.1038\/s41467-024-46448-9","article-title":"Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus","volume":"15","author":"Doglio","year":"2024","journal-title":"Nat Commun"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.686439","article-title":"Precision engineering of an anti-HLA-A2 chimeric antigen receptor in regulatory T cells for transplant immune tolerance","volume":"12","author":"Muller","year":"2021","journal-title":"Front Immunol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1172\/JCI82771","article-title":"Alloantigen-specific regulatory T cells generated with a chimeric antigen receptor","volume":"126","author":"MacDonald","year":"2016","journal-title":"J Clin Invest"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.15787","article-title":"Donor-specific chimeric antigen receptor Tregs limit rejection in naive but not sensitized allograft recipients","volume":"20","author":"Sicard","year":"2020","journal-title":"Am J Transplant"},{"key":"B32","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/TP.0000000000004316","article-title":"Do treg speed up with CARs? Chimeric antigen receptor treg engineered to induce transplant tolerance","volume":"107","author":"Kaljanac","year":"2023","journal-title":"Transplantation"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.92865","article-title":"T cells expressing chimeric antigen receptor promote immune tolerance","volume":"2","author":"Pierini","year":"2017","journal-title":"JCI Insight"},{"key":"B34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/35876","article-title":"A B-cell-homing chemokine made in lymphoid follicles activates Burkitt\u2019s lymphoma receptor-1","volume":"391","author":"Gunn","year":"1998","journal-title":"Nature"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2337\/db12-1258","article-title":"Alloantibody and autoantibody monitoring predicts islet transplantation outcome in human type 1 diabetes","volume":"62","author":"Piemonti","year":"2013","journal-title":"Diabetes"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-11-4494","article-title":"Balanced expression of CXCR5 and CCR7 on follicular T helper cells determines their transient positioning to lymph node follicles and is essential for efficient B-cell help","volume":"106","author":"Hardtke","year":"2005","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.182.1.148","article-title":"Levels of Foxp3 in regulatory T cells reflect their functional status in transplantation","volume":"182","author":"Chauhan","year":"2009","journal-title":"J Immunol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024226","article-title":"Helios expression is a marker of T cell activation and proliferation","volume":"6","author":"Akimova","year":"2011","journal-title":"PloS One"},{"key":"B39","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/eji.201847935","article-title":"Helios(+) and Helios(-) Treg subpopulations are phenotypically and functionally distinct and express dissimilar TCR repertoires","volume":"49","author":"Thornton","year":"2019","journal-title":"Eur J Immunol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1111\/hae.12646","article-title":"A longitudinal evaluation of anti-FVIII antibodies demonstrated IgG4 subclass is mainly correlated with high-titre inhibitor in haemophilia A patients","volume":"21","author":"Montalvao","year":"2015","journal-title":"Haemophilia"},{"key":"B41","doi-asserted-by":"publisher","first-page":"7906724","DOI":"10.1155\/2019\/7906724","article-title":"Mouse IgG2a Antibodies Specific for the Commensal Streptococcus mitis Show Stronger Cross-Reactivity with Streptococcus pneumoniae than IgG1 Antibodies","volume":"2019","author":"Shekhar","year":"2019","journal-title":"J Immunol Res"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1005582","article-title":"Membrane-bound IL-2 improves the expansion, survival, and phenotype of CAR Tregs and confers resistance to calcineurin inhibitors","volume":"13","author":"Kremer","year":"2022","journal-title":"Front Immunol"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1172\/JCI139991","article-title":"Selective expansion of regulatory T cells using an orthogonal IL-2\/IL-2 receptor system facilitates transplantation tolerance","volume":"131","author":"Hirai","year":"2021","journal-title":"J Clin Invest"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2023.04.021","article-title":"A chemically inducible IL-2 receptor signaling complex allows for effective in vitro and in vivo selection of engineered CD4+ T cells","volume":"31","author":"Cook","year":"2023","journal-title":"Mol Ther"},{"key":"B45","doi-asserted-by":"publisher","first-page":"110830","DOI":"10.1016\/j.isci.2024.110830","article-title":"CXCR4-enriched T regulatory cells preferentially home to bone marrow and resolve inflammation","volume":"27","author":"Huang","year":"2024","journal-title":"iScience"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00507","article-title":"Extracellular NGFR spacers allow efficient tracking and enrichment of fully functional CAR-T cells co-expressing a suicide gene","volume":"9","author":"Casucci","year":"2018","journal-title":"Front Immunol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-08-732636","article-title":"NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease","volume":"130","author":"Mastaglio","year":"2017","journal-title":"Blood"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-2498-1_13","article-title":"In vitro assay to sensitively measure T(FR) suppressive capacity and T(FH) stimulation of B cell responses","volume":"1291","author":"Sage","year":"2015","journal-title":"Methods Mol Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.21769\/BioProtoc.2743","article-title":"Murine pancreatic islets transplantation under the kidney capsule","volume":"8","author":"Jofra","year":"2018","journal-title":"Bio Protoc"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142906","article-title":"B cell-activating factor modulates the factor VIII immune response in hemophilia A","volume":"131","author":"Doshi","year":"2021","journal-title":"J Clin Invest"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1513009\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T08:51:34Z","timestamp":1751359894000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1513009\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":50,"alternative-id":["10.3389\/fimmu.2025.1513009"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1513009","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"article-number":"1513009"}}